Skip to content

Advertisement

  • Research note
  • Open Access

Evaluation of the effect of a floxed Neo cassette within the dystroglycan (Dag1) gene

BMC Research Notes201710:601

https://doi.org/10.1186/s13104-017-2926-9

  • Received: 18 April 2017
  • Accepted: 10 November 2017
  • Published:

Abstract

Objective

Dystroglycan (DG) is an adhesion complex formed by two subunits, α-DG and β-DG. In skeletal muscle, DG is part of the dystrophin-glycoprotein complex that is crucial for sarcolemma stability and it is involved in a plethora of muscular dystrophy phenotypes. Due to the important role played by DG in skeletal muscle stability as well as in a wide variety of other tissues including brain and the peripheral nervous system, it is essential to investigate its genetic assembly and transcriptional regulation.

Results

Herein, we analyze the effect of the insertion of a floxed neomycin (Neo) cassette within the 3′ portion of the universally conserved IG1-intron of the DG gene (Dag1). We analyzed the transcription level of Dag1 and the expression of the DG protein in skeletal muscle of targeted mice compared to wild-type and we did not find any alterations that might be attributed to the gene targeting. However, we found an increase of the cross-sectional areas of tibialis anterior that might have some physiological significance that needs to be assessed in the future. Moreover, in targeted mice the skeletal muscle morphology and its regeneration capacity after injury did not show any evident alterations. We confirmed that the targeting of Dag1 with a floxed Neo-cassette did not produce any gross undesired effects.

Keywords

  • Dystroglycan
  • Skeletal muscle
  • Incomplete recombination

Introduction

Dystroglycan (DG) is a widely expressed adhesion complex encoded by a single gene (Dag1) as a unique precursor that undergoes post-translational cleavage to generate two interacting subunits: the extracellular and highly glycosylated α-DG and the transmembrane β-DG [1, 2].

DG is crucial for cell membrane stability connecting the actin cytoskeleton to extracellular matrix (ECM) proteins [3]. Whenever the DG/ECM axis is perturbed, severe muscular dystrophy phenotypes do arise [4, 5].

Extensive genetic work has been carried out in order to analyze the function of DG in several tissues [6]. It was shown that the knockout of Dag1 in mice is embryonic lethal [7]. This result is in line with what was observed in some human patients, in which a homozygous loss-of-function mutation in Dag1 results in the absence of DG that leads to early postnatal lethality [8].

Conditional knockouts of Dag1 in several tissues have confirmed the importance of DG for tissue stability. In those studies, no apparent effects of the inserted floxed Neo cassette have been reported [911]. Moreover, the knock-in mouse carrying the pathological mutation T190M showed an evident muscular dystrophy phenotype and possible effects arising from the presence of the exogenous genetic elements might have been covered up [12]. On the other hand, in the knock-in mouse Y890F the floxed-Neo cassette had been already removed in the chimeric mice and no effect arising from the presence of the remaining LoxP element has been reported [13].

Interestingly, the insertion of a floxed Neo-cassette can lead to a significantly reduced expression of the target gene and can also downregulate the transcription of genes located at a distance of several kilobases from it [1422].

Considering the lack of experimental data on the effects of the floxed Neo cassette on Dag1 expression, we have decided to assess whether the presence of a floxed Neo cassette or single floxed site in the Dag1 allele might have per se some evident functional consequences for Dag1 expression in skeletal muscle.

Main text

Methods

Generation of targeting vector

Genomic DNA from V6.4 murine ES (embryonic stem) cells, (genotype C57BL/6J × 129/SvJae), was used as a template to amplify the right and left hand arms of the DG targeting construct. The 5′ arm of the construct consisted of 3.2 kb of intronic sequences amplified from the Dag1 intron using the following primers: forward 5′-GAGTAAGACTTTGTCTATAAAACA-3′ and reverse 5′-AAACCCCAACAACTACGGTCCTCA-3′. The 3′ arm was 4 kb in length, consisted of the exon 3 region, harboring four mutations, flanked by intronic sequences and the 3′-UTR, respectively, was amplified using the following primers: forward 5′-GAGAAGTGGGATTCATTTAGACAG-3′ and reverse 5′GAATGTAATCTTTAGCTACTGTT-3′. To allow the linearization of the targeting vector that is necessary for the recombination and integration of the construct into the ES cells genome, site-directed mutagenesis was used to mutate a XhoI site in the 5′ arm using the QuikChange site-directed mutagenesis kit (Stratagene®) and the following primers: forward 5′-AGTTCCTTCCTGCCTAGAGTGGGTGTTCCCT-3′ and reverse 5′-AGGGAACACCCACTCTAGGCAGGAAGGAACT-3′ (mutated nucleotides in bold). Both the right and left hand arms were initially cloned into separate TOPO vectors (Invitrogen) and then sub-cloned into the final targeting vector, a modified pBluescript KS vector containing a floxed neomycin cassette under the PGK promoter (Fig. 1a). The 5′ and 3′ arms were cloned within a BamHI and HindIII sites respectively. Both enzymes (New England Biolabs® Inc) were incubated at 37 °C for 1.5 h. The Herpes simplex thymidine kinase (HSVtk) cassette acts as a negative selection marker. The targeting vector was used at the Core Facility for Conditional Mutagenesis, Dibit-San Raffaele Scientific Institute, Milan to electroporate and analyze murine ES cells by Southern blot. One homologous recombinant ES clone was microinjected into blastocysts from 129 J mice. The resulting chimeras were then bred with C57BL6 mice to generate germ line-transmitted heterozygous mice (Dag1 Neo/+). Dag1 Neo/+ mice were backcrossed into the C57BL/6 background for ten generations and then used to create the experimental colonies. Mice from different colonies were crossbred to generate wild-type (Dag1 +/+), heterozygous (Dag1 Neo/+) and homozygous mice (Dag1 Neo/Neo ).
Fig. 1
Fig. 1

Organization of the dystroglycan gene and position of the floxed Neo cassette. a Schematic representation of the Dag1 +/+ allele, the targeting vector, the Dag1 allele after incomplete homologous recombination (Dag1 Neo ) and the neo-deleted allele (Dag1 ΔNeo ). The 5′ arm of the construct consisted of a 3.2 kb fragment amplified from the Dag1 intron. The 3′ arm was 4 kb in length and consisted of the exon 3′ region, harbouring four mutations (red asterisks) hitting the α/β-DG interface, and flanked by intronic sequences and the 3′-UTR, respectively. A XhoI (X) site in the 5′ arm was mutated for cloning purposes. The floxed neomycin cassette (Neo) and the Herpes simplex thymidine kinase (TK) acted as positive and negative selection markers, respectively. Selected restriction enzyme cleavage sites are indicated above the gene (B: BamHI; H: HindIII and X: XhoI). Primers used for genotyping are also indicated as black arrows. b A representative PCR genotyping analysis of the Dag1 Neo/+ mouse. The PCR product was amplified from genomic DNA using primers spanning the Neo cassette region

To remove the Neo cassette, homozygotes were crossbred with male transgenic mice expressing the transgene Cre under the CMV promoter (Jackson Laboratories) to generate Dag1 Neo/+ mice. Female F1 animals were bred again with homozygous Dag1 Neo/Neo mice to generate Dag1 ΔNeo/ΔNeo mice.

Creatine kinase assay

Fresh serum was collected by retro-orbital bleeding. The creatine kinase (CK) level was determined according to the International Federation of Clinical Chemistry with commercial reagents on the Cobas 8000/c701® (Roche Diagnostics).

Histological and immunofluorescence analysis

All the analyses described below were not performed blind. Tibialis anterior (TA) and gastrocnemius (GA) muscles of 5 months-old female mice (n = 4 per genotype) were embedded in Jung tissue freezing medium and frozen in liquid nitrogen-cooled isopentane. Frozen sections (7 μm) were stained with hematoxylin and eosin (HE) using standard methods [23]. Fiber cross-sectional areas (CSA) of muscle sections were counted manually using ImageJ (NIH, Bethesda, MD) from 6 to 12 randomly selected fields per section. At least 150 fibres per mouse from three mice per genotype were counted.

For the immunofluorescences analysis, TA muscle frozen sections of 5 months-old female mice were incubated with the following antibodies diluted in PBS containing 1% BSA (Sigma-Aldrich): mouse monoclonal anti-α-DG IIH6 (Millipore, code 05–593) (1:100), rabbit polyclonal anti-β-DG (Abcam, code ab43125) (1:300) and rat monoclonal anti-laminin-α2 clone 4H8-2 (Sigma-Aldrich, code L0663) (1:100). The primary antibodies were followed by the appropriate secondary goat anti-mouse IgM (for IIH6), goat anti mouse, anti rat or anti rabbit IgG antibodies conjugated with Alexa®488 or Alexa®633 fluorophores (1:500) (Invitrogen-Thermo Fisher Scientific). Muscle sections incubated with the only secondary antibody were used as control to validate the primary antibody specificity. Sections were viewed with a Leica SP2 microscope and all images were analyzed using ImageJ software (NIH).

Cardiotoxin injury

TA muscles of female 5 months-old mice (four mice per group) were injured along the entire length of the muscle with cardiotoxin (CTX) (LATOXAN SAS, code L8102) injections, 5 μL of 10 μM CTX in saline solution. These conditions ensured muscle damage a uniform manner. The muscles were harvested 10 days after cardiotoxin-induced damage. Frozen sections were processed for histological analysis. Contralateral intact muscles were used as a control. In our previous study, regeneration was fully active at 7 days after injury [24]. Sections were viewed with a Leica SP2 microscope and all images were analyzed using ImageJ software (NIH).

Western blotting

TA muscle proteins from 5 months-old mice were extracted with PBS 1% Triton-X100 containing protease inhibitors. 20 μg of soluble proteins were analyzed in Western blot as described elsewhere [24] using the following antibodies: anti mouse α-DG IIH6 (Millipore) (1:1000), anti rabbit β-DG (Abcam) (1:1000) and anti-tubulin HRP-conjugated (Abcam) antibodies.

RT-PCR

RNA was isolated from frozen muscle using the RNeasy Fibrous Tissue Mini Kit. Reverse Trascriptase PCR reactions were carried out using 3 μg of RNA. Quantitative RT-PCR was performed in triplicate using a standard TaqMan® PCR protocol on a StepOne Real time PCR System (Applied Biosystems). Probes were specific for mouse Dag1 and mouse Gadph genes. Data analysis was performed as described elsewhere [25].

Statistical analysis

Data were expressed as mean ± standard error of the mean (SE). Comparisons among groups were performed using an analysis of variance (One-way ANOVA) followed by a Bonferroni’s post hoc multiple comparison test to determine statistical significance of the differences among the four experimental mice groups; p value of < 0.05 was considered to be statistically significant. Statistical analyses were performed with SPSS software (version 17.0, Chicago, IL, US).

Results and discussion

Insertion of the floxed Neo cassette into Dag1 and removal by Cre recombinase: the Dag1 Neo/Neo and Dag1 ΔNeo/ΔNeo mouse lines

In an attempt to produce a novel DG knock-in mouse line harboring four mutations at the α/β-DG interface [26], an incomplete homologous recombination at the 3′ arm (Fig. 1) prevented the generation of the desired mutated mouse line. Indeed, we generated and studied a mouse line with a Dag1 allele in which a Neo cassette, flanked by two LoxP sites, was inserted into the second intron (Dag1 Neo allele) (Fig. 1).

The Neo cassette was introduced in the second intron (also termed IG1-intron since it interrupts the structure of the IG1 domain within the structurally autonomous N-terminal region of α-DG [27]). In addition, we have also crossbred our mice with a mouse line that expresses the Cre recombinase under a CMV-promoter and results in Cre-mediated recombination in germ line. This resulted in the Cre-driven excision of the floxed Neo cassette in the targeted Dag1 (Dag1 ΔNeo allele, Fig. 1a, b).

Histological and molecular analysis of skeletal muscle

Animals with two wild-type alleles are denoted by “Dag1 +/+”, mouse lines in which one allele carries the floxed Neo cassette are designated “Dag1 Neo/+”, whilst their homozygous counterpart is denoted by “Dag1 Neo/Neo ”. Finally, “Dag1 ΔNeo/ΔNeo ” indicates the mouse line obtained upon the excision of the Neo cassette by Cre recombinase.

At 5 months of age, body weights of Dag1 Neo/+ (male 31.5 g ± 2.3; female 25 g ± 1.7), Dag1 Neo/Neo (male 31.7 g ± 2.6; female 24.5 g ± 1.5) and Dag1 ΔNeo/ΔNeo (male 31.8 g ± 2.2; female 26 g ± 1.1) mice were not significantly different from wild-type controls (male 31.8 g ± 2.5; female 25 g ± 1.5).

Histology of tibialis anterior (TA) and gastrocnemius (GA) muscles of 5 months-old female mice, derived from crosses between heterozygotes (intercross) belonging to different colonies, examined by HE staining did not show any gross morphological sign indicating skeletal muscle alterations in Dag1 Neo/+, Dag1 Neo/Neo , and Dag1 ΔNeo/ΔNeo mice compared to Dag1 +/+ controls (Fig. 2). In all the Dag1 targeted mice, the levels of serum CK, a marker for skeletal muscle damage, did not significantly differ from those of wild-type animals (female: Dag1 +/+ 366 U/L ± 0.8; Dag1 Neo/+ 370 U/L ± 0.8; Dag1 Neo/Neo 355 U/L ± 0.7; Dag1 ΔNeo/ΔNeo 360 U/L ± 0.85). CK was measured in 3 and 5-months old mice. Immunofluorescence analysis showed the expected localization of the two DG subunits as well as of the DG major skeletal muscle binding partner laminin to the cell membrane and cell surface, respectively (Fig. 3). Western blot analysis confirmed that the DG precursor is correctly cleaved into its two subunits and that α-DG is highly glycosylated in all the lines (Fig. 4a). The levels of α- and β-DG were similar compared to wild-type mice (data not shown).
Fig. 2
Fig. 2

Histological analysis of skeletal muscle. Hematoxylin and eosin staining of transverse frozen sections of tibialis anterior muscle of 5 months old Dag1 +/+, Dag1 Neo/+, Dag1 Neo/Neo , and Dag1 ΔNeo/ΔNeo female mice (4 mice per group). No dramatic abnormalities were observed in the skeletal muscle morphology of the targeted mice compared to their wild-type counterparts. Scale bar = 50 μm

Fig. 3
Fig. 3

Immunofluorescence staining of skeletal muscle tissue sections. Immunolabeling of a α-DG and b β-DG and laminin-α2 of 5 months old mice tibialis anterior muscle. Scale bar = 20 μm

Fig. 4
Fig. 4

Western blot analysis. Representative immunoblotting of total protein lysates from Dag1 +/+, Dag1 Neo/+, Dag1 Neo/Neo , and Dag1 ΔNeo/ΔNeo skeletal muscle. Upper panel; α-DG probed with IIH6 antibody specific for the α-DG carbohydrates epitopes; middle panel: tubulin used as loading control; lower panel: β-DG probed with the anti 43-DAG antibody showing the correct processing of the DG precursor

Next, we examined the muscle fiber cross-sectional areas (CSA) by sampling a set of muscle fiber size in TA (Fig. 5a) and GA (Fig. 5b) muscle within the four experimental groups (four mice per group). Overall, we found a significant difference of the medians of fiber CSAs between the groups (lines) of mice (p < 0.001) whereas in GA we did not find any difference (p = 0.998). In particular, in TA muscle the CSA in mouse line Dag1 ΔNeo/ΔNeo (mean 1826 μm2 ± 37) was significantly increased when compared with Dag1 +/+ mice (mean 1609 μm2 ± 36) (p < 0.001). At present, we cannot rule out that the observed variability in TA might have significant physiological repercussions. Further investigations will be required to better clarify this point.
Fig. 5
Fig. 5

Analysis of skeletal muscle fiber cross-sectional areas (CSA). a Tibialis anterior (TA) muscle and b gastrocnemius (GA) muscle of Dag1 +/+, Dag1 Neo/+, Dag1 Neo/Neo , and Dag1 ΔNeo/ΔNeo 5-months old female mice (4 mice per group). *Indicates significant difference (p < 0.001). Error bars represent SEM

The increase of TA muscle fibers was not mirrored by an increase either in DG protein levels or in Dag1 transcription (see below) (Figs. 4, 6). The Dag1 transcription levels were measured by Real Time PCR experiments that monitor the changes in mRNA levels of Dag1 Neo/Neo , and Dag1 ΔNeo/ΔNeo mice relative to Dag1 +/+ littermates and no significant change was detected (p = 0.707) (Fig. 6).
Fig. 6
Fig. 6

Quantitative analysis of Dag1 expression in skeletal muscle of 5 months old Dag1 +/+, Dag1 Neo/+, Dag1 Neo/Neo , and Dag1 ΔNeo/ΔNeo mice. Total mRNA was purified from tibialis anterior skeletal muscle of 5 months old mice and retro-transcribed to cDNA. Real-Time PCR reactions were performed using probes for the Dag1 and Gadph genes. Results are expressed as fold change of Dag1 expression in Dag1 Neo/+ (n = 4), Dag1 Neo/Neo (n = 4), and Dag1 ΔNeo/ΔNeo (n = 4) lines relative to the Dag +/+ line (n = 4). No significant difference was noted between any of the genotypes (p = 0.707). Error bars represent SEM

Cardiotoxin-induced skeletal muscle regeneration

Dystroglycan is essential for postnatal muscle growth, stability and regeneration [9, 28]. To further analyze the possible presence of skeletal muscle defects of the regenerative process, we analyzed the TA muscles of Dag1 Neo/+, Dag1 Neo/Neo , and Dag1 ΔNeo/ΔNeo 5-months old female mice compared to Dag1 +/+ mice, 10 days after CTX-induced damage. HE staining revealed that, although CTX injection caused muscle necrosis with the accumulation of mononucleated infiltrating cells, the regeneration response occurred in all the analysed muscles, as demonstrated by the amount of central nucleated fibers present (p = 0.559) (Fig. 7).
Fig. 7
Fig. 7

Assessment of skeletal muscle regeneration in Dag1 +/+, Dag1 Neo/+, Dag1 Neo/Neo , and Dag1 ΔNeo/ΔNeo mice. Skeletal muscle regeneration process after CTX injection was not affected in Dag1 Neo/+, Dag1 Neo/Neo , and Dag1 ΔNeo/ΔNeo 5 months old mice compared to Dag1 +/+ mice. a Hematoxylin and eosin staining of transverse frozen sections of tibialis anterior muscle. b Quantification of the number of centrally nucleated fibers in mice 10 days after the injection with CTX. Centrally nucleated fibers were counted from five randomly selected fields per section to evaluate fibre regeneration (four mice per group). No significant difference was found among the four experimental groups (p = 0.559). Error bars represent SEM

Limitations

The targeting of Dag1 with a floxed Neo cassette did not produce any strong undesired skeletal muscle phenotype. The increase of CSA that we observed in TA of Dag1 ΔNeo/ΔNeo mice might be due to some degree of variability between the analyzed mice, but must be further analyzed. Dag1 second intron is large (10 Kb) and this justifies the absence of relevant effects on Dag1 mRNA upon the introduction of the floxed Neo-cassette [29].

Declarations

Authors’ contributions

Conceived and designed the experiments: FS, AB. Performed the experiments: FS, BMS, GS, MGB, BT, MB. Analysed the data: FS, BMS, FL GS, BG, SB, AB. Wrote the paper: FS, AB. All authors reviewed and contributed to the various draft versions of the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We gratefully acknowledge Massimo Aquilina and Fabrizio Fiore from the animal facility of the Catholic University of Rome for their skillful assistance, and Alexandra Joyner, Memorial Sloan Kettering Cancer Center New York, for the PGK-Neo plasmid.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Consent for publication

Not applicable.

Ethics approval and consent to participate

All animal procedures were approved by the Ethics Committee of the Animal Facility of the Università Cattolica del Sacro Cuore (UCSC, Roma, Prot. Sf 11100/13 and Prot. CE 20353/14 06_01) and by the Italian Ministry of Health, Direzione Generale della Sanità Animale e dei Farmaci Veterinari (196/2015-PR).

Funding

This work was supported by a Wellcome Trust Career Re-entry fellowship to MGB and by an AFM post-doctoral fellowship to FS. This work was in part supported by a PRIN 20109MXHMR_001 Grant to BG.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Istituto di Chimica del Riconoscimento Molecolare (CNR), c/o Università Cattolica del Sacro Cuore, Rome, Italy
(2)
Istituto di Istologia, Università Cattolica del Sacro Cuore, Rome, Italy
(3)
Istituto di Biochimica e Biochimica Clinica, Università Cattolica del Sacro Cuore, Rome, Italy
(4)
School of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK
(5)
Istituto di Clinica delle Malattie Infettive, Università Cattolica del Sacro Cuore, Rome, Italy
(6)
Neurodevelopmental Genetics, Institute of Reconstructive Neurobiology, Life and Brain Center, University of Bonn, Bonn, Germany

References

  1. Bozzi M, Morlacchi S, Bigotti MG, Sciandra F, Brancaccio A. Functional diversity of dystroglycan. Matrix Biol. 2009;28:179–87.View ArticlePubMedGoogle Scholar
  2. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 1992;35:696–702.View ArticleGoogle Scholar
  3. Moore CJ, Winder SJ. The inside and out of dystroglycan post-translational modification. Neuromuscul Disord. 2012;22:959–65.View ArticlePubMedGoogle Scholar
  4. Endo T. Glycobiology of α-dystroglycan and muscular dystrophy. J Biochem. 2015;157:1–12.View ArticlePubMedGoogle Scholar
  5. Zhang QZ. Dystroglycan induced muscular dystrophies—a review. Eur Rev Med Pharmacol Sci. 2016;20:3683–7.PubMedGoogle Scholar
  6. Sciandra F, Bigotti MG, Giardina B, Bozzi M, Brancaccio A. Genetic engineering of dystroglycan in animal models of muscular dystrophy. Biomed Res Int. 2015;2015:635792.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Williamson RA, Henry MD, Daniels KJ, Hrstka RF, Lee JC, Sunada Y, et al. Dystroglycan is essential for early embryonic development: disruption of Reichert’s membrane in Dag1-null mice. Hum Mol Genet. 1997;6:831–41.View ArticlePubMedGoogle Scholar
  8. Riemersma M, Mandel H, van Beusekom E, Gazzoli I, Roscioli T, Eran A, et al. Absence of α- and β-dystroglycan is associated with Walker-Warburg syndrome. Neurology. 2015;84:2177–82.View ArticlePubMedGoogle Scholar
  9. Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, Moore SA, et al. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell. 2002;110:639–48.View ArticlePubMedGoogle Scholar
  10. Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature. 2002;418:422–5.View ArticlePubMedGoogle Scholar
  11. Saito F, Moore SA, Barresi R, Henry MD, Messing A, Ross-Barta SE, et al. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron. 2003;38:747–58.View ArticlePubMedGoogle Scholar
  12. Hara Y, Balci-Hayta B, Yoshida-Moriguchi T, Kanagawa M, Beltrán-Valero de Bernabé D, Gündeşli H, et al. A dystroglycan mutation associated with limb-girdle muscular dystrophy. N Engl J Med. 2011;364:939–46.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Miller G, Moore CJ, Terry R, La Riviere T, Mitchell A, Piggott R, et al. Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse. Hum Mol Genet. 2012;21:4508–20.View ArticlePubMedGoogle Scholar
  14. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380:435–9.View ArticlePubMedGoogle Scholar
  15. Meyers EN, Lewandoski M, Martin GR. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet. 1998;18:136–41.View ArticlePubMedGoogle Scholar
  16. Nagy A, Moens C, Ivanyi E, Pawling J, Gertsenstein M, Hadjantonakis AK, et al. Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr Biol. 1998;8:661–4.View ArticlePubMedGoogle Scholar
  17. Shannon MB, Patton BL, Harvey SJ, Miner JH. A hypomorphic mutation in the mouse laminin alpha5 gene causes polycystic kidney disease. J Am Soc Nephrol. 2006;17:1913–22.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Ackroyd MR, Skordis L, Kaluarachchi M, Godwin J, Prior S, Fidanboylu M, et al. Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies. Brain. 2009;132:439–51.View ArticlePubMedGoogle Scholar
  19. Rijli FM, Dolle P, Fraulob V, LeMeur M, Chambon P. Insertion of a targeting construct in a Hoxd-10 allele can influence the control of Hoxd-9 expression. Dev Dyn. 1994;201:366–77.View ArticlePubMedGoogle Scholar
  20. Fiering S, Epner E, Robinson K, Zhuang Y, Telling A, Hu M, et al. Targeted deletion of 5′HS2 of the murine β-globin LCR reveals that it is not essential for proper regulation of the β-globin locus. Genes Dev. 1995;9:2203–13.View ArticlePubMedGoogle Scholar
  21. Pham CT, MacIvor DM, Hug BA, Heusel JW, Ley TJ. Long-range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci USA. 1996;93:13090–5.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Meier ID, Bernreuther C, Tilling T, Neidhardt J, Wong YW, Schulze C. Short DNA sequences inserted for gene targeting can accidentally interfere with off-target gene expression. FASEB J. 2010;24:1714–24.View ArticlePubMedGoogle Scholar
  23. Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harbor Protoc. 2008;3(5). https://doi.org/10.1101/pdb.prot4986.
  24. Toschi A, Severi A, Coletti D, Musarò A, Molinaro M, et al. Skeletal muscle regeneration in mice is stimulated by local overexpression of V1a-vasopressin receptor. Mol Endocrinol. 2011;25:1661–73.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;6:1101–8.View ArticleGoogle Scholar
  26. Sciandra F, Bozzi M, Morlacchi S, Galtieri A, Giardina B, Brancaccio A. Mutagenesis at the α-β interface impairs the cleavage of the dystroglycan precursor. FEBS J. 2009;276:4933–45.View ArticlePubMedGoogle Scholar
  27. Brancaccio A, Schulthess T, Gesemann M, Engel J. The N-terminal region of α-dystroglycan is an autonomous globular domain. Eur J Biochem. 1997;246:166–72.View ArticlePubMedGoogle Scholar
  28. Rader EP, Turk R, Willer T, Beltrán D, Inamori KI, Peterson TA, et al. Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle. Proc Natl Acad Sci USA. 2016;113:10992–7.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Brancaccio A. DAG1, no gene for RNA regulation? Gene. 2012;497:79–82.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2017

Advertisement